» Articles » PMID: 24228068

Nanoparticle Toxicity by the Gastrointestinal Route: Evidence and Knowledge Gaps

Overview
Date 2013 Nov 15
PMID 24228068
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

The increasing interest in nanoparticles for advanced technologies, consumer products, and biomedical applications has led to great excitement about potential benefits but also concern over the potential for adverse human health effects. The gastrointestinal tract represents a likely route of entry for many nanomaterials, both directly through intentional ingestion or indirectly via nanoparticle dissolution from food containers or by secondary ingestion of inhaled particles. Additionally, increased utilisation of nanoparticles may lead to increased environmental contamination and unintentional ingestion via water, food animals, or fish. The gastrointestinal tract is a site of complex, symbiotic interactions between host cells and the resident microbiome. Accordingly, evaluation of nanoparticles must take into consideration not only absorption and extraintestinal organ accumulation but also the potential for altered gut microbes and the effects of this perturbation on the host. The existing literature was evaluated for evidence of toxicity based on these considerations. Focus was placed on three categories of nanomaterials: nanometals and metal oxides, carbon-based nanoparticles, and polymer/dendrimers with emphasis on those particles of greatest relevance to gastrointestinal exposures.

Citing Articles

Silver Nanoparticles as Antimicrobial Agents in Veterinary Medicine: Current Applications and Future Perspectives.

Frippiat T, Art T, Delguste C Nanomaterials (Basel). 2025; 15(3).

PMID: 39940178 PMC: 11820087. DOI: 10.3390/nano15030202.


Predicting Bioaccumulation of Nanomaterials: Modeling Approaches with Challenges.

Zeng H, Lv Z, Sun X, Tong Y, Wu W, Dong S Environ Health (Wash). 2024; 2(4):189-201.

PMID: 39474143 PMC: 11503807. DOI: 10.1021/envhealth.3c00138.


An insight into impact of nanomaterials toxicity on human health.

Qamar W, Gulia S, Athar M, Ahmad R, Imam M, Chandra P PeerJ. 2024; 12:e17807.

PMID: 39364370 PMC: 11448750. DOI: 10.7717/peerj.17807.


Emerging trends and future challenges of advanced 2D nanomaterials for combating bacterial resistance.

Hameed S, Sharif S, Ovais M, Xiong H Bioact Mater. 2024; 38:225-257.

PMID: 38745587 PMC: 11090881. DOI: 10.1016/j.bioactmat.2024.04.033.


Cell-derived nanomaterials for biomedical applications.

Yip L, Wang J, Xue Y, Xing K, Sevencan C, Ariga K Sci Technol Adv Mater. 2024; 25(1):2315013.

PMID: 38476511 PMC: 10930141. DOI: 10.1080/14686996.2024.2315013.


References
1.
Evans D, Pye G, Bramley R, Clark A, Dyson T, Hardcastle J . Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut. 1988; 29(8):1035-41. PMC: 1433896. DOI: 10.1136/gut.29.8.1035. View

2.
Loginova Y, Dezhurov S, Zherdeva V, Kazachkina N, Wakstein M, Savitsky A . Biodistribution and stability of CdSe core quantum dots in mouse digestive tract following per os administration: advantages of double polymer/silica coated nanocrystals. Biochem Biophys Res Commun. 2012; 419(1):54-9. DOI: 10.1016/j.bbrc.2012.01.123. View

3.
de Jong W, Borm P . Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine. 2008; 3(2):133-49. PMC: 2527668. DOI: 10.2147/ijn.s596. View

4.
Park K, Park E, Chun I, Choi K, Lee S, Yoon J . Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats. Arch Pharm Res. 2011; 34(1):153-8. DOI: 10.1007/s12272-011-0118-z. View

5.
Bilberg K, Doving K, Beedholm K, Baatrup E . Silver nanoparticles disrupt olfaction in Crucian carp (Carassius carassius) and Eurasian perch (Perca fluviatilis). Aquat Toxicol. 2011; 104(1-2):145-52. DOI: 10.1016/j.aquatox.2011.04.010. View